Clark School Home UMD

Press Release Story

New microsystems detect, treat bacterial biofilms that cause post-operative infections

'Flexible impedance sensor' can fit inside urinary catheters; monitor and treat biofilm.

previousPrev     Nextprevious

FOR IMMEDIATE RELEASE  November 28, 2017


Rebecca Copeland
301 405 6602


A long-term, interdisciplinary research collaboration at the University of Maryland’s A. James Clark School of Engineering has made significant progress in detecting and treating bacterial biofilms by developing new chemical compounds, materials, and microsystems that can fight these sources of post-operative infections.

In their 10-year collaboration, Professor Reza Ghodssi (Department of Electrical and Computer Engineering; Institute for Systems Research), Professor William Bentley (Fischell Department of Bioengineering; Robert E. Fischell Institute for Biomedical Devices), and their students and colleagues have advanced the state of the art in both biofilm detection and treatment. They have developed microsystems that can detect and measure biofilm as well as microsystems for biofilm treatment. The most recent device, which can be placed in urinary catheters, can do all three.

Doctors need far better ways to detect, measure, and effectively treat bacterial biofilms, which are almost always involved in device-associated and post-operative infections and account for approximately half of all the estimated 700,000 to 2 million hospital infections annually. They form when planktonic bacteria adhere to moist surfaces, then secrete proteins and carbohydrate polymers that form an encasing “extracellular matrix.” This matrix makes it easier for them to adhere to the surface, to communicate and to spread through gene transfer. It also offers significant protection for the bacteria against antimicrobial medicines.

Biofilms easily form on implanted medical devices such as catheters, prosthetic joints, and dental implants. Urinary catheters, some of the most commonly inserted medical devices, are susceptible to biofilm forming from bacteria in the urine at a rate of 5–7 percent per day. Because high doses of antibiotics are required for their removal, biofilms contribute to the increase in antibiotic-resistant strains of bacteria.

New detection and treatment methods for biofilms

“Our work develops future technologies such as flexible substrates and devices that we hope soon will be able to combat the formation of bacterial biofilms and treat their associated infections in patients,” Ghodssi says.

The researchers developed a variety of treatments that can reduce or eliminate the need for antibiotics. They worked with colleagues from materials science and engineering, bioengineering and chemical and biomolecular engineering to develop chemical compounds called quorum sensing inhibitors which can prevent biofilm formation by interrupting the pathways by which bacteria communicate. “The idea is to shut off communicating cells and make them susceptible to various treatments,” says Bentley.

They also advanced surface coatings, such as liquid-infused surfaces, micro/nano structured surfaces, and antimicrobial-infused surfaces, that make it harder for biofilms to attach to medical devices.

In addition, they developed electroceuticals that use electric fields to generate biofilm-killing toxic compounds. In an action called the bioelectric effect, a small electric field increases the efficacy of an antimicrobial medicine, such as an antibiotic or quorum sensing inhibitor. Adding the electric field to treatment lowers the amount of antimicrobial needed to be effective, helping slow the increase in antibiotic-resistant bacteria.

In conjunction with the advances in treatment, the researchers also developed ways to measure the presence and growth of biofilms, including optical sensing systems that measure changes in opacity that accompany biofilm formation, surface acoustic wave sensors that quantify the mass of a biofilm as it forms and alters a surface’s resonant frequency, and microelectrodes that measure biofilm growth through electrochemical analysis.

The researchers have built microsystems that bring all these advances together to both measure and treat biofilm. Over the years they have refined and incorporated these systems into small, biocompatible, and flexible devices.

A biofilm sensing and treatment device for catheters

The new flexible impedance sensor brings several of these advances together in one device. It is a biofilm sensing and treatment microsystem for urinary catheters that combines biofilm sensing and the bioelectric effect treatment in a flexible cylindrical tube. The device is rolled and inserted inside the catheter, where its microfabricated polymeric substrate and electrodes seamlessly conform to the catheter’s surface. The concept also has the potential to work on other kinds of biofilm-susceptible surfaces, such as implanted medical devices.

Catheters with this device will be able to simultaneously monitor film formation and implement bioelectric effect-based synergistic treatments to remove them. Its electrodes expose the biofilm to a small electric field which synergistically increases the effectiveness of antimicrobial treatment and significantly lowers the dosage of antibiotics needed for biofilm removal. A patent application has been submitted.

Experts cite demonstrated potential and continuing progress

“In addition to detecting the formation of the biofilm by optical, acoustic, and impedance techniques, this research group has demonstrated that applying electric fields renders the biofilm much more susceptible to antibiotics,” writes Roger Howe, the William E. Ayer Professor of Engineering in the Department of Electrical Engineering at Stanford University. “The impact of this research, as it transitions into biomedical devices, will be to reduce infections while simultaneously reducing the dosage of antibiotics—a major contribution to improving healthcare.”

“Drs. Ghodssi, Bentley, and colleagues at the University of Maryland have developed several model systems that can provide sensitive, real-time detection of microbial biofilms, suggesting the potential for new approaches for biofilm surveillance on indwelling medical devices,” says Rodney Donlan, a biofilm microbiologist at the Centers for Disease Control and Prevention in Atlanta.

The work is progressing towards multidimensional, challenging environments like detecting and treating biofilm infections in patients or monitoring for biofilm growth in environments such as water pipes, according to Ghodssi, with a goal of smart, self-sustaining, flexible sensors.

“We are so excited that these efforts will be among the first devices developed by our new Robert E. Fischell Institute for Biomedical Devices,” says Bentley. “It will bring together these kinds of multidisciplinary approaches and talented individuals to build systems that make a difference.”


More Information: 

MEMS Sensors and Actuators Laboratory
Bentley research group
Institute for Systems Research
Fischell Department of Bioengineering
Robert E. Fischell Institute for Biomedical Devices
A. James Clark School of Engineering

Faculty and students involved


Professor Reza Ghodssi (ECE/ISR)
Professor William Bentley (BIOE/Robert E. Fischell Institute for Biomedical Devices)
Associate Professor Herman O. Sintim (Chemistry & Biochemistry, Purdue University)
Professor Mark Austin (CEE/ISR)
Professor Gregory Payne (Fischell Department of Bioengineering and Institute for Bioscience and Biotechnology Research)
Professor Gary Rubloff (MNE/ISR)

Students and postdoctoral researchers

Varnika Roy (BioE Ph.D. 2011) was advised by William Bentley. She is a scientist at Medimmune.
Jacqueline Smith
(Chemistry Ph.D. 2011) was advised by Herman Sintim at the University of Maryland. She is a postdoctoral researcher at Georgetown University.
Matthew Mosteller
(MSSE 2012) was advised by Reza Ghodssi and Mark Austin. He is a technology specialist and patent Agent at Fish & Richardson P.C., and a student at the Georgetown University Law School.
Mariana Meyer
(BioE Ph.D. 2014) was advised by Reza Ghodssi. She is a multifunction engineer in the professional development program at Northrop Grumman Corporation.
Young Wook Kim
(EE Ph.D. 2014) was advised by Reza Ghodssi. He is a senior researcher and deputy general manager at Seegene, Inc. in Songpa-gu, Seoul, South Korea.
Hadar Ben-Yoav
(Postdoctoral Researcher 2011-2015) is a senior lecturer (assistant professor) at the Ben Gurion University of the Negev in Israel.
Sowmya Subramanian
(EE Ph.D. 2016) was advised by Reza Ghodssi. She is now a staff scientist at Choate, Hall & Stewart LLP in Boston.
Ekaterina (Kate) Tolstaya (B.S. EE, B.S. CS 2016) is currently a graduate student at the University of Pennsylvania with an NSF Graduate Research Fellowship. As an undergraduate, she worked on supercapacitors and sensors to monitor biofilm growth.
Ryan Huiszoon (BioE) is a current Ph.D. student advised by Reza Ghodssi.


National Science Foundation Emerging Frontiers in Research and Innovation (EFRI): Biofunctionalized Devices—On Chip Signaling and "Rewiring" Bacterial Cell-Cell Communication

Robert W. Deutsch Foundation